EPS for Cantel Medical Corp. (CMD) Expected At $0.60 as of May, 31

May 16, 2018 - By Fidelia Bagby

Earnings report for Cantel Medical Corp. (NYSE:CMD) is awaited on May, 31 before the open., according to Faxor. This year’s EPS analyst estimate is awaited to be $0.60. That is 17.65 % up compareed to $0.51 EPS for last year. CMD’s profit could hit $25.03M if the current EPS of $0.60 is accurate. Wall Street sees 1.69 % EPS growth as of May, 31. CMD hit $127.48 during the last trading session after $2.59 change.Currently Cantel Medical Corp. is uptrending after 41.41% change in last May 17, 2017. CMD has 217,886 shares volume. CMD outperformed by 29.86% the S&P500.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide.The company has $5.32 billion market cap. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis.The P/E ratio is 59.13. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

There’s an important Cantel Medical Corp. (NYSE:CMD) news announced by Benzinga.com. It’s an article titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” on May 15, 2018.

Cantel Medical Corp. (NYSE:CMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: